Longfellow Investment Management’s Phillips 66 PSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,262
Closed -$403K 289
2025
Q1
$403K Hold
3,262
0.1% 116
2024
Q4
$372K Buy
3,262
+956
+41% +$122K 0.1% 117
2024
Q3
$303K Buy
2,306
+13
+0.6% +$1.75K 0.08% 130
2024
Q2
$324K Buy
2,293
+15
+0.7% +$2.22K 0.08% 119
2024
Q1
$372K Sell
2,278
-2,152
-49% -$310K 0.08% 116
2023
Q4
$590K Sell
4,430
-3,591
-45% -$429K 0.15% 81
2023
Q3
$964K Sell
8,021
-2,623
-25% -$294K 0.26% 57
2023
Q2
$1.02M Buy
10,644
+433
+4% +$42.1K 0.23% 62
2023
Q1
$1.04M Hold
10,211
0.24% 67
2022
Q4
$1.06M Hold
10,211
0.24% 75
2022
Q3
$824K Hold
10,211
0.17% 112
2022
Q2
$838K Hold
10,211
0.18% 108
2022
Q1
$883K Hold
10,211
0.14% 130
2021
Q4
$740K Buy
10,211
+1,261
+14% +$95.3K 0.12% 139
2021
Q3
$627K Hold
8,950
0.1% 147
2021
Q2
$769K Sell
8,950
-5,853
-40% -$494K 0.11% 153
2021
Q1
$1.21M Sell
14,803
-2,202
-13% -$173K 0.15% 157
2020
Q4
$1.19M Buy
+17,005
New +$998K 0.14% 144

Other funds holding PSX

Longfellow Investment Management's PSX Position: Q2 2025 in Review

Longfellow Investment Management sold out of Phillips 66 (PSX) in Q2 2025, closing a stake of 3,262 shares — an estimated $403K sold.

Longfellow Investment Management first reported a position in PSX in Q4 2020 and held it in 18 quarters. The position peaked at $1.21M in Q1 2021. 1,763 funds tracked by Wall St. Rank hold PSX as of Q2 2025.

  • Longfellow Investment Management reported no remaining Phillips 66 position as of Q2 2025 after selling out during the quarter.
  • Longfellow Investment Management sold 3,262 Phillips 66 shares in Q2 2025, an estimated $403K.
  • Longfellow Investment Management first reported a position in Phillips 66 in Q4 2020 and held it in 18 quarters.
  • Longfellow Investment Management's Phillips 66 position peaked at $1.21M in Q1 2021.
  • 1,763 funds tracked by Wall St. Rank held Phillips 66 as of Q2 2025.

Based on Longfellow Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.